Keywords: fda, accepts, axcan, nda, ursodiol, pbc, therapy

FDA Accepts Axcan NDA For Ursodiol As PBC Therapy

Article | 16 September 1996

Print This

Canadian firm Axcan Pharma says its New Drug Application for URSO (ursodeoxycholic acid; UDCA) in the treatment of primary biliary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in